Stat News: Lawmakers want to remove gag clauses that boost drug costs at the pharmacy counter
Mark Merritt said “we always support, as an industry, patients paying lower price at the counter…it’s an outlier practice.”
Mark Merritt said “we always support, as an industry, patients paying lower price at the counter…it’s an outlier practice.”
The Pharmaceutical Care Management Association, which represents PBMs, has defended DIR fees as appropriate and based on pharmacy performance. “We are currently reviewing the proposed rule. However, previous point-of-sale proposals in Medicare have not advanced because they significantly increase Medicare spending,” said Greg Lopes, a spokesperson for PCMA.
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. P&T COMMITTEES FOLLOW THE SCIENCE… Covering effective drugs for the broad
Pharmacy Benefit Managers reduce prescription drug costs for patients and use innovative technology to help patients get their prescriptions and lead healthier lives.
In case you missed it, Ike Brannon, health care economist and senior fellow at the Jack Kemp Foundation, published a new white paper, “Recently Proposed Federal and State Legislation To Constrain Pharmacy Benefit Managers Would Not Reduce Drug Costs,” in
(Washington, D.C.) — As drugstore lobbyists today push their agenda in Springfield, the Pharmaceutical Care Management Association (PCMA) released the following statement: “Pharmacy benefit managers (PBMs) advocate on behalf of Illinois’ consumers and health plan sponsors by negotiating with drug
Economists Explain Policies Restricting Pharmacy Benefits Will Lead To Higher Costs, Less Competition, And Fewer Choices For Employers In case you missed it, Joe Grogan, visiting senior fellow at the USC Schaeffer Center and former White House domestic policy adviser,
(Washington, D.C.) — Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6), which requires electronic prescribing (e-prescribing) of controlled substances in Medicare. This is an important step in the fight against America’s
©2024 PCMA. All Rights Reserved.